Skip to main content

Animations

MJFF Publications

2521 - 2530 of 8823 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2021
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13690
    Citation Count: 9
  • Summary Details
    OPEN
    Title: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13678
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging
    Journal Name: Journal of Clinical Sleep Medicine
    Publisher: American Academy of Sleep Medicine (AASM)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.5664/jcsm.9562
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Reply to: “Age‐Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK‐PD)”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28920
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease Revisited
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29133
    Citation Count: 12
  • Summary Details
    OPEN
    Title: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Rosmarinic Acid Potently Detoxifies Amylin Amyloid and Ameliorates Diabetic Pathology in a Transgenic Rat Model of Type 2 Diabetes
    Journal Name: ACS Pharmacology & Translational Science
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsptsci.1c00028
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.1c00453
    Citation Count: 96
  • Summary Details
    OPEN
    Title: Tandem Ring Opening/Intramolecular [2 + 2] Cycloaddition Reaction for the Synthesis of Cyclobutane Fused Thiazolino-2-Pyridones
    Journal Name: The Journal of Organic Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.joc.1c01875
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.